10 years ago
Could Ebola vaccine delay be due to an intellectual property spat?
Questions remain over why a made-in-Canada experimental Ebola vaccine is still sitting in a Winnipeg laboratory instead of being dispensed in West Africa, with a scientific journal suggesting an intellectual property dispute may be to blame.
Continue Reading
http://www.cbc.ca
Join the Discussion